Heritage Investors Management Corp Trims Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Heritage Investors Management Corp trimmed its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 4.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 118,369 shares of the company’s stock after selling 5,090 shares during the period. Heritage Investors Management Corp’s holdings in Takeda Pharmaceutical were worth $1,689,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. FMR LLC grew its stake in shares of Takeda Pharmaceutical by 4.7% in the third quarter. FMR LLC now owns 2,593,350 shares of the company’s stock valued at $40,119,000 after buying an additional 115,947 shares in the last quarter. Brandes Investment Partners LP increased its holdings in Takeda Pharmaceutical by 2.1% during the 3rd quarter. Brandes Investment Partners LP now owns 1,802,036 shares of the company’s stock worth $27,877,000 after purchasing an additional 36,717 shares during the period. Managed Asset Portfolios LLC boosted its stake in shares of Takeda Pharmaceutical by 1.5% in the 3rd quarter. Managed Asset Portfolios LLC now owns 1,736,416 shares of the company’s stock valued at $26,862,000 after buying an additional 25,291 shares during the period. Envestnet Asset Management Inc. increased its stake in shares of Takeda Pharmaceutical by 5.7% during the third quarter. Envestnet Asset Management Inc. now owns 1,512,936 shares of the company’s stock worth $23,405,000 after buying an additional 81,267 shares during the period. Finally, Van ECK Associates Corp lifted its stake in Takeda Pharmaceutical by 3.6% in the fourth quarter. Van ECK Associates Corp now owns 1,323,916 shares of the company’s stock worth $18,892,000 after acquiring an additional 45,616 shares during the last quarter. Hedge funds and other institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Stock Up 2.5 %

TAK stock traded up $0.32 during midday trading on Thursday, reaching $13.38. 2,941,880 shares of the company were exchanged, compared to its average volume of 1,792,912. The stock’s 50-day simple moving average is $13.82 and its 200 day simple moving average is $14.09. Takeda Pharmaceutical Company Limited has a 1-year low of $12.77 and a 1-year high of $17.03. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.55 and a current ratio of 1.06. The company has a market cap of $42.35 billion, a price-to-earnings ratio of 20.26, a price-to-earnings-growth ratio of 3.05 and a beta of 0.56.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.